|
US4038479A
(en)
*
|
1969-11-17 |
1977-07-26 |
Burroughs Wellcome Co. |
Amino purine derivatives
|
|
US3887706A
(en)
*
|
1969-12-12 |
1975-06-03 |
Schering Ag |
N6-(3-Chlorobuten-2-yl)-adenosines as anti-inflammatory agents
|
|
DE2059922A1
(de)
*
|
1970-12-05 |
1972-06-15 |
Boehringer Mannheim Gmbh |
Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben
|
|
US4027026A
(en)
*
|
1971-03-09 |
1977-05-31 |
Smith Kline & French Laboratories Limited |
Pharmaceutical compositions and methods of inhibiting H-2 histamine receptors with pyridyl substituted thioalkyl- and oxyalkyl-thioureas and ureas
|
|
BE788958A
(fr)
*
|
1971-09-18 |
1973-03-19 |
Schering Ag |
Derives d'adenosine et leur procede de preparation
|
|
BE789773A
(fr)
*
|
1971-10-08 |
1973-04-06 |
Schering Ag |
Adenosines n6 -substituees et leur procede de
|
|
US4090021A
(en)
*
|
1971-10-08 |
1978-05-16 |
Schering Aktiengesellschaft |
Process for the production of N6 -substituted adenosine nucleotides and products resulting therefrom
|
|
DE2157036A1
(de)
*
|
1971-11-17 |
1973-05-24 |
Boehringer Mannheim Gmbh |
Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
|
|
DE2244328A1
(de)
*
|
1972-09-09 |
1974-03-21 |
Boehringer Mannheim Gmbh |
Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
|
|
DE2359536C2
(de)
*
|
1972-12-08 |
1984-08-02 |
Takeda Chemical Industries, Ltd., Osaka |
2,6-Diaminonebularinderivate
|
|
US4016262A
(en)
*
|
1973-08-01 |
1977-04-05 |
Boehringer Mannheim G.M.B.H. |
Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds
|
|
DE2338963A1
(de)
*
|
1973-08-01 |
1975-02-13 |
Boehringer Mannheim Gmbh |
Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
|
|
US3992531A
(en)
*
|
1973-12-26 |
1976-11-16 |
Abbott Laboratories |
2-Substituted adenosine-5'-carboxylates in the treatment of anginal pain
|
|
US4171432A
(en)
*
|
1978-06-22 |
1979-10-16 |
Miles Laboratories, Inc. |
Flavin adenine dinucleotide-iodothyronine conjugates
|
|
JPS57171998A
(en)
*
|
1981-04-15 |
1982-10-22 |
Fujisawa Pharmaceut Co Ltd |
Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
|
|
CA1239397A
(en)
*
|
1983-08-01 |
1988-07-19 |
James A. Bristol |
N.sup.6-substituted adenosines
|
|
US4501735A
(en)
*
|
1983-12-05 |
1985-02-26 |
Warner-Lambert Company |
N6-(1- and 2-benzocycloalkyl) adenosines
|
|
DE3406533A1
(de)
*
|
1984-02-23 |
1985-08-29 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
|
|
EP0300144A3
(en)
*
|
1984-04-18 |
1989-09-27 |
Whitby Research Incorporated |
N-6 alkyl substituted adenosine derivatives as cardiac vasodilators
|
|
US5310731A
(en)
*
|
1984-06-28 |
1994-05-10 |
Whitby Research, Inc. |
N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
|
|
CA1254888A
(en)
*
|
1984-10-26 |
1989-05-30 |
Bharat Trivedi |
N.sup.6-bicycloadenosines
|
|
US4614732A
(en)
*
|
1984-10-26 |
1986-09-30 |
Warner-Lambert Company |
N6 -acenaphthyl adenosines and analogs thereof
|
|
AU579412B2
(en)
*
|
1984-10-26 |
1988-11-24 |
Warner-Lambert Company |
N` - substituted adenosines
|
|
US4593019A
(en)
*
|
1984-10-26 |
1986-06-03 |
Warner-Lambert Company |
N6 -tricyclic adenosines
|
|
US4673670A
(en)
*
|
1985-09-05 |
1987-06-16 |
Warner-Lambert Company |
N6 -acenaphthyl adenosines and analogs thereof
|
|
US4954504A
(en)
*
|
1986-11-14 |
1990-09-04 |
Ciba-Geigy Corporation |
N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
|
|
US5063233A
(en)
*
|
1986-11-14 |
1991-11-05 |
Ciba-Geigy Corporation |
N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
|
|
JPH0723394B2
(ja)
*
|
1986-11-27 |
1995-03-15 |
日本臓器製薬株式会社 |
新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
|
|
US4968697A
(en)
*
|
1987-02-04 |
1990-11-06 |
Ciba-Geigy Corporation |
2-substituted adenosine 5'-carboxamides as antihypertensive agents
|
|
US5034381A
(en)
*
|
1988-01-07 |
1991-07-23 |
Ciba-Geigy Corporation |
2-(substituted amino) adenosines as antihypertensives
|
|
US5032584A
(en)
*
|
1988-10-26 |
1991-07-16 |
G. D. Searle & Co. |
S-diastereomer of an n6 -((2-hydroxypropyl)aryl)adenosine and its medicinal uses
|
|
US5030624A
(en)
*
|
1988-10-26 |
1991-07-09 |
G. D. Searle & Co. |
R-diastereomer of an N6 -[(2-hydroxypropyl)aryl]adenosine and its medicinal uses
|
|
US4992535A
(en)
*
|
1988-10-26 |
1991-02-12 |
G. D. Searle & Co. |
Methods of making novel R and S diastereomers of N6 -[(2-hydroxypropyl)aryl]adenosines
|
|
US5391739A
(en)
*
|
1989-03-29 |
1995-02-21 |
Merrell Dow Pharmaceuticals Inc. |
Selective adenosine receptor agents
|
|
US5256650A
(en)
*
|
1989-03-29 |
1993-10-26 |
Merrell Dow Pharmaceuticals Inc. |
Selective adenosine receptor agents
|
|
DK62592D0
(xx)
*
|
1992-05-14 |
1992-05-14 |
Novo Nordisk As |
|
|
US5672588A
(en)
*
|
1992-05-20 |
1997-09-30 |
Novo Nordisk A/S |
Purine derivatives
|
|
GB9312853D0
(en)
*
|
1993-06-22 |
1993-08-04 |
Euro Celtique Sa |
Chemical compounds
|
|
US5683989A
(en)
*
|
1993-12-17 |
1997-11-04 |
Novo Nordisk A/S |
Treatment of ischemias by administration of 2,N6 -substituted adenosines
|
|
US5922751A
(en)
*
|
1994-06-24 |
1999-07-13 |
Euro-Celtique, S.A. |
Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
|
|
US5591776A
(en)
*
|
1994-06-24 |
1997-01-07 |
Euro-Celtique, S.A. |
Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
|
|
AU4527896A
(en)
*
|
1994-12-13 |
1996-07-03 |
Euro-Celtique S.A. |
Aryl thioxanthines
|
|
US6025361A
(en)
*
|
1994-12-13 |
2000-02-15 |
Euro-Celtique, S.A. |
Trisubstituted thioxanthines
|
|
ATE247655T1
(de)
*
|
1994-12-13 |
2003-09-15 |
Euro Celtique Sa |
Dreifachsubstituierte thioxanthine
|
|
US6166041A
(en)
*
|
1995-10-11 |
2000-12-26 |
Euro-Celtique, S.A. |
2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
|
|
US6075016A
(en)
*
|
1996-04-10 |
2000-06-13 |
Euro-Celtique S.A. |
6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
|
|
US5864037A
(en)
|
1996-06-06 |
1999-01-26 |
Euro-Celtique, S.A. |
Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
|
|
TWI229674B
(en)
|
1998-12-04 |
2005-03-21 |
Astra Pharma Prod |
Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
|
|
US6784165B1
(en)
*
|
1999-11-23 |
2004-08-31 |
Aderis Pharmaceuticals, Inc. |
Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
|
|
AU3540101A
(en)
*
|
2000-01-07 |
2001-07-16 |
Universitaire Instelling Antwerpen |
Purine derivatives, process for their preparation and use thereof
|
|
CZ294538B6
(cs)
*
|
2002-12-30 |
2005-01-12 |
Ústav Experimentální Botaniky Akademie Vědčeské Re |
Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
|
AU2004238217A1
(en)
*
|
2003-04-24 |
2004-11-25 |
Aderis Pharmaceuticals, Inc. |
Method of treating atrial fibrillation or atrial flutter
|
|
WO2005025545A2
(en)
*
|
2003-09-17 |
2005-03-24 |
Aderis Pharmaceuticals, Inc. |
Pharmaceutical formulation for controlled release of selodenoson
|
|
CZ2009298A3
(cs)
*
|
2009-05-14 |
2010-11-24 |
Univerzita Palackého v Olomouci |
Substituované 6-benzylaminopurin ribosidy, jejich použití a farmaceutický prípravek tyto slouceniny obsahující
|
|
ES2645043T3
(es)
*
|
2009-11-13 |
2017-12-01 |
Academia Sinica |
Compuestos de doble acción que se dirigen al receptor A2A de adenosina y al transportador de adenosina para la prevención y el tratamiento de enfermedades neurodegenerativas
|